Related Experiment Videos
Prescribing antibiotics for impetigo
1Launceston General Hospital, Tasmania, Australia.
Abstract:
Impetigo, a contagious superficial pyogenic infection of the skin, can be treated orally or topically. Nowadays oral erythromycin is the treatment of choice, although flucloxacillin is preferred in areas where the causative micro-organisms are resistant to erythromycin. Topical mupirocin ointment has shown itself to be as effective as oral therapy in many cases and is less likely to be associated with unwanted effects. The availability of 2 forms of therapy-oral and topical-means that treatment can be tailored according to the preferences of the patient. Consequently, drug therapy is more likely to be used appropriately. Arguments for and against the prescribing of each form of therapy are presented.
Insights
Impetigo treatment options include oral erythromycin or topical mupirocin. Both methods are effective, but topical therapy may have fewer side effects and allow for personalized patient care.
Area of Science:
- Dermatology
- Infectious Diseases
- Pharmacology
Background:
- Impetigo is a common, contagious bacterial skin infection.
- Treatment involves either oral or topical antimicrobial agents.
- Current guidelines often recommend oral erythromycin, with flucloxacillin as an alternative for resistant strains.
Purpose of the Study:
- To compare the efficacy and safety of oral versus topical treatments for impetigo.
- To discuss the advantages and disadvantages of each therapeutic approach.
- To inform clinical decision-making regarding impetigo management.
Main Methods:
- Review of existing literature on impetigo treatment.
- Analysis of clinical trial data comparing oral and topical therapies.
- Consideration of microbial resistance patterns and patient factors.
Main Results:
- Topical mupirocin demonstrates comparable efficacy to oral erythromycin in many cases.
- Topical therapy is associated with a lower incidence of adverse effects.
- Both oral and topical treatments are effective for impetigo.
Conclusions:
- Treatment choice for impetigo can be individualized based on patient preference and local resistance patterns.
- Topical mupirocin offers a viable alternative to oral antibiotics, potentially improving patient compliance and tolerability.
- Optimizing treatment selection enhances appropriate drug utilization for impetigo.